Fundraising FoxXerient
2 known investors
Find your way into Xerient
Sign up to find every way you can get introduced to Xerient
- Your email: who you already know at Xerient, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Xerient team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Xerient do?
- Xerient is a biopharmaceutical company developing oncology treatments, with expertise in clinical trial design, radiation oncology, and translational cancer research for gastrointestinal malignancies.
- Who founded Xerient?
- Xerient was founded by Guy Yachin, Dr. Michael Shtein, Prof. Cullen Taniguchi.
- Who are Xerient's investors?
- Xerient's investors include Peregrine Ventures, SIBF (Southern Israel Bridging Fund) VC.